Pretty sure the references to 2019 are mostly to the 2019 FY ie now - it’s an annual report for the FY18 year so the context is important but maybe they are interchangeable in their minds.
As for the ‘fiends’ buying on dips - they seem to be there - after the price tradded 2.7c on a few thousand we saw 1.5m bid at 2.8c and the it was bid at 2.9c so selling remains light and buying hidden.
I appreciate the understated way they seem to have moved to 3 primary and 3 secondary candidates/areas (platform in action?) but I am most curious about inlicencing a flagship thing - I doubt it is the MYC stuff or it would have got a mention but these guys seem to choose their words intentionally so they have something in mind/train IMHO. Talk of human trials and IND again - does sound like 2019 CY or FY is significant.
Glad the references to Genetech are there and that 2019 (calendar or FY?) is a decision time for them too.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.27 |
Change
0.025(2.02%) |
Mkt cap ! $723.2M | |||
| Open | High | Low | Value | Volume |
| $1.25 | $1.27 | $1.25 | $16.96K | 13.58K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 12227 | $1.26 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.28 | 1049 | 1 |
View Market Depth
| Last trade - 10.02am 25/06/2025 (20 minute delay) ? |
| PYC (ASX) Chart |